Vuno invests $2M, sells lung AI in Japan to rival
Vuno has invested in and offered its lung illness prognosis AI know-how in Japan to its rival Korean firm Coreline Comfortable.
The 2 corporations lately entered right into a strategic partnership to collectively elevate their competitiveness within the rising international medical imaging AI phase.
Vuno invested 3.4 billion received ($2.3 million) in Coreline Comfortable, to which it offered and transferred the rights of its AI-powered lung illness prognosis help software program – its first providing in Japan. This then marks Coreline Comfortable’s entry into the Japanese market, which is famous for having some of the energetic investments in AI-based medical know-how.
“If AI corporations similar to Vuno and Coreline Comfortable work collectively strategically whereas upgrading their respective core companies, we’re assured that we will broaden our competitiveness within the international market,” Vuno CEO Lee Ye-Ha mentioned in a press release.
Vatech, Medit to combine dental AI
South Korean digital dentistry corporations Vatech and Medit have partnered with United States-based Pearl for dental AI integration.
Pearl’s AI, which may robotically establish dental pathologies, will probably be built-in into Vatech’s diagnostic software program and upcoming built-in viewer software program and Medit’s centralised digital workflow platform.
Indian e-pharmacy scores $44M Collection C funding
Truemeds, a digital pharmacy and telehealth platform in India, has raised Rs 375 crore ($44 million) in a Collection C funding spherical led by Accel India and took part by WestBridge and Data Edge.
The corporate raised the quantity from issuing shares to Accel India, which now holds a ten% stake within the firm; WestBridge and Data Edge additionally elevated their stakes to 29% and 23%, respectively.
In keeping with a regulatory submitting with the federal government, it plans to make use of the proceeds of the fundraising to pursue its progress plans.
Truemeds final raised $22 million in Collection B funding in 2022.
Korea College Medical Middle to check voice-based coronary heart failure AI
Korea College Medical Middle (KUMC) has signed a memorandum of understanding with startup a.treatment to assist additional develop the latter’s AI know-how.
The startup, to which KUMC transferred the rights to an AI-based know-how for diagnosing pulmonary congestion in October, is at the moment creating a brand new AI for diagnosing and predicting coronary heart failure based mostly on voice information.
Underneath their MOU, each events will cooperate to check and commercialise a.treatment’s newest AI product. The startup can have entry to huge information and medical analysis capabilities and community of KUMC. The hospital may also help a.treatment in securing investments regionally and overseas.
In the meantime, a.treatment will collaborate with the hospital for R&D initiatives with the federal government and for acquiring regulatory licenses.
Korea approves osteoporosis AI
Promedius, one other Korean medical AI firm, has lately acquired regulatory approval from the South Korean Ministry of Meals and Drug Security (MFDS).
It acquired the MFDS clearance for its osteoporosis prognosis help AI software program. The corporate claims that its chest X-ray-based software program is inexpensive than a bone density check and has decrease radiation publicity danger than a volumetric bone density check.
